Michigan State University scientists will use the latest CRISPR technology to study two extremely rare genetic mutations that leave children severely disabled with seizures and involuntary movements. CRISPR,…
Two rare diseases caused by a malfunctioning gene that triggers seizures or involuntary movements in children as early as a few days old have left scientists searching for…
Michigan State University researchers have discovered that a chemical compound, and potential new drug, reduces the spread of melanoma cells by up to 90 percent. The man-made, small-molecule…
This year, four Michigan State University scientists were named AAAS Fellows by the American Association for the Advancement of Science. This national recognition is awarded to researchers for…
Richard Neubig, chair of the Department of Pharmacology and Toxicology at Michigan State University, discusses the potential for pharmacological intervention in scleroderma/systemic sclerosis cases. This presentation was given at…
Research at Michigan State University